Surbhi Sarna is the Founder and CEO of Collate, which uses AI to create and maintain the regulatory and quality documentation that diagnostic, medical-device, and drug-development companies need, shortening their time to market. Before Collate she was a General Partner at Y Combinator, where she was its first partner focused on healthcare and biotech. She earlier founded nVision Medical, which Boston Scientific acquired for $275 million in 2018. Sarna is a UC Berkeley alumna with a background in microbiology and bioengineering.